Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoFreshfields advises Hintco on the import of renewable ammoniaRead MoreFacebookX.comPinterestLinkedinEmail830160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoRopes & Gray Advises BE Semiconductor Industries N.V. on €350 Million Bond OfferingRead MoreFacebookX.comPinterestLinkedinEmail839160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoDLA Piper advises Triton Pacific and ACON in its sale of BioMatrix to Frazier HealthcareRead MoreFacebookX.comPinterestLinkedinEmail835160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoClifford Chance advises on a tender offer for Comarch sharesRead MoreFacebookX.comPinterestLinkedinEmail841160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoClifford Chance advises dsm-firmenich on the sale of its MEG-3® fish oil business to KD Pharma GroupRead MoreFacebookX.comPinterestLinkedinEmail845160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoClifford Chance advises Equistone on the intended sale of Heras to Garda GroupRead MoreFacebookX.comPinterestLinkedinEmail857170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoClifford Chance advises Cassa Depositi e Prestiti in the issuance of its first Digital Bond on BlockchainRead MoreFacebookX.comPinterestLinkedinEmail850170
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoKirkland Advises Commure on Take-Private Acquisition of AugmedixRead MoreFacebookX.comPinterestLinkedinEmail833160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoKirkland Advises Evolution AB on Galaxy Gaming AcquisitionRead MoreFacebookX.comPinterestLinkedinEmail849160
Upvote0Points0PointsUpvotes:0Downvotes:0Total Votes:0DownvoteNitya VashishthaDeals1 year agoLatham & Watkins Advises on Artiva Biotherapeutics’ US$167 Million Initial Public OfferingRead MoreFacebookX.comPinterestLinkedinEmail840160
